Management of DR-TB ADR: Hematological Abnormalities
Adverse Drug Reactions (ADRs), such as haematological abnormalities, may occur from the Drug-resistant TB (DR-TB) treatment regimen.
Suspected agent(s): Linezolid (Lzd)
Suggested Management Strategies